 constructed the
targeting vector for ge nerating the PS-K196E and PS-KO mice; J.H.G.
made recombinant murine APC and PS, interpreted data, and wrote
the paper; and T.M. designed research, interpreted data, and wrote
the paper.
Conﬂict-of-interest disclosure: The authors declare no competing
ﬁnancial interests.
Correspondence: Toshiyuki Miyata, Department of Cerebrovas-
cular Medicine, National Cerebral and Cardiovascular Center, 5-7-1
Fujishirodai, Suita, Osaka 565-8565, Japan; e-mail: miyata@ncvc.
go.jp.
Figure 5. Transient MCA occlusion model using the 3-VO technique. (A)
Representative images of coronal sections of Pros11/1,Pros11/E,Pros1E/E, and
Pros11/2mouse brains. (B) Infarct volumes. No significant differences ( P..05)
were observed among the groups. Symbols represent data from a single mouse.
Bars represent the mean values of groups.2252 BANNO et al BLOOD, 5 NOVEMBER 2015 xVOLUME 126, NUMBER 19References
1. Dahlb¨ ack B. The tale of protein S and C4b-binding
protein, a story of affection. Thromb Haemost.
2007;98(1):90-96.
2. Griffin JH, Zlokovic BV, Mosnier LO. Protein C
anticoagulant and cytoprotective pathways. Int J
Hematol. 2012;95(4):333-345.
3. Saller F, Brisset AC, Tchaikovski SN, et al.
Generation and phenotypic analysis of protein S-
deficient mice. Blood. 2009;114(11):2307-2314.
4. Garc ´ıa de Frutos P, Fuentes-Prior P, Hurtado B,
Sala N. Molecular basis of protein S deficiency.
Thromb Haemost. 2007;98(3):543-556.
5. G´ omez E, Ledford MR, Pegelow CH, Reitsma PH,
Bertina RM. Homozygous protein S deficiency
due to a one base pair deletion that leads to a stop
codon in exon III of the protein S gene. Thromb
Haemost. 1994;71(6):723-726.
6. Hayashi T, Nishioka J, Shigekiyo T, Saito S,
Suzuki K. Protein S Tokushima: abnormal
molecule with a substitution of Glu for Lys-155 in
the second epidermal growth factor-like domain of
protein S. Blood. 1994;83(3):683-690.
7. Yamazaki T, Sugiura I, Matsushita T, et al. A
phenotypically neutral dimorphism of protein S:
the substitution of Lys155 by Glu in the second
EGF domain predicted by an A to G base
exchange in the gene. Thromb Res. 1993;70(5):
395-403.
8. Kinoshita S, Iida H, Inoue S, et al. Protein S and
protein C gene mutations in Japanese deep vein
thrombosis patients. Clin Biochem. 2005;38(10):
908-915.
9. Kimura R, Honda S, Kawasaki T, et al. Protein S-
K196E mutation as a genetic risk factor for deep
vein thrombosis in Japanese patients. Blood.
2006;107(4):1737-1738.
10. Ikejiri M, Wada H, Sakamoto Y, et al. The
association of protein S Tokushima-K196E with
a risk of deep vein thrombosis. Int J Hematol.
2010;92(2):302-305.
11. Yin T, Miyata T. Dysfunction of protein C
anticoagulant system, main genetic risk factor for
venous thromboembolism in northeast Asians.
J Thromb Thrombolysis. 2014;37(1):56-65.
12. Kimura R, Sakata T, Kokubo Y, et al. Plasma
protein S activity correlates with protein S
genotype but is not sensitive to identify K196E
mutant carriers. J Thromb Haemost. 2006;4(9):
2010-2013.
13. Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic
risk factors for deep vein thrombosis among
Japanese: importance of protein S K196E
mutation. Int J Hematol. 2006;83(3):217-223.
14. Miyata T, Hamasaki N, Wada H, Kojima T.
More on: racial differences in venous
thromboembolism. J Thromb Haemost. 2012;
10(2):319-320.
15. Neki R, Fujita T, Kokame K, et al. Genetic
analysis of patients with deep vein thrombosis
during pregnancy and postpartum. Int J Hematol.
2011;94(2):150-155.
16. Miyata T, Sato Y, Ishikawa J, et al. Prevalence
of genetic mutations in protein S, protein C and
antithrombin genes in Japanese patients with
deep vein thrombosis. Thromb Res. 2009;124(1):
14-18.
17. Neki R, Miyata T, Fujita T, et al. Nonsynonymous
mutations in three anticoagulant genes in
Japanese patients with adverse pregnancy
outcomes. Thromb Res. 2014;133(5):914-918.
18. Pecheniuk NM, Elias DJ, Xu X, Griffin JH. Failure
to validate association of gene polymorphisms inEPCR, PAR-1, FSAP and protein S Tokushima
with venous thromboembolism among Californians
of European ancestry. Thromb Haemost.
2008;99(2):453-455.
19. Liu W, Yin T, Okuda H, et al. Protein S K196E
mutation, a genetic risk factor for venous
thromboembolism, is limited to Japanese. Thromb
Res. 2013;132(2):314-315.
20. Goldhaber SZ. Race and venous
thromboembolism: nature or nurture? Circulation.
2014;129(14):1463-1465.
21. Kujovich JL. Factor V Leiden thrombophilia.
Genet Med. 2011;13(1):1-16.
22. Dahlb¨ ack B. Advances in understanding
pathogenic mechanisms of thrombophilic
disorders. Blood. 2008;112(1):19-27.
23. Ridker PM, Hennekens CH, Lindpaintner K,
Stampfer MJ, Eisenberg PR, Miletich JP. Mutation
in the gene coding for coagulation factor V and the
risk of myocardial infarction, stroke, and venous
thrombosis in apparently healthy men. N Engl J
Med. 1995;332(14):912-917.
24.